22nd Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology
jointly with 42nd Annual Meeting of Japanese Society of Newropsychopharmacology

October 18-20, 2012
Tochigi prefectural General Culture Center,
Utsunomiya Hotel Grande, Utsunomiya Japan

FIRST AUTHOR INDEX
First Name	Last Name	No.	Title
Lerer	Bernard	SL-1	Schizophrenia, impaired reality testing and the AHI1 gene: From men to mice
Lee	Min-Soo	SL-2	Advances of pharmacogenetics in psychiatry
Kennedy	Sidney H.	CL-1	Measurement in clinical trials: Right scales for the right patients
TAKARADA	TAKESHI	S11-1	NMDA receptor and uncoupling protein
FURUKAWA	TOSHIAKI	S12-2	Strategic use of new generation antidepressants for depression
NAKAMURA	MITSUHIRO	EN-1	Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs:A propensity-matched analysis from the japanese diagnosis procedure combination database
SUGAI	TAKURO	EN-2	Excessive insulin secretion in Japanese schizophrenic patients treated with antipsychotics, despite normal fasting glucose levels
SUZUKI	TAKEFUMI	AB	My 2-year clinical experiences in Toronto
Lerer	Bernard	LS2-A	Parallels and contrasts in the genetics and psychopharmacology of schizophrenia and bipolar disorder
Lee	Min-Soo	LS2-B	New alternative to depression based on epidemiology and treatment of depression in Korea
Serretti	Alessandro	LS3-A	What shall we know for more appropriate use of antidepressant drugs? Lessons from pharmacology and genetics of SSRI
Keck	Paul	LS3-B	Evidence-based treatment of bipolar mania
Kennedy	Sidney H.	EV2-C	Duloxetine: Update in effi cacy and effectiveness
WATANABE	TAKASHI	O1-F4	Serotonin transporter gene-linked polymorphic region infl uences discontinuation of pharmacotherapy with paroxetine in panic disorder
TANI	HIDEAKI	O1-D-11	Interventions to Reduce Antipsychotic Polypharmacy: A Systematic Review
MORIGUCHI	SHO	O1-D-15	D2 Receptor Occupancy and Remission in Schizophrenia: Analysis of the CATIE
SAKURAI	HITOSHI	O1-F-10	Trajectories of Individual Symptoms in Remitters versus Non-Remitters with Depression
HIRANO	JINICHI	O1-F-12	Adjunctive acetaminophen therapy for major depression: a preliminary report
SUGAI	TAKURO	O2-B-2	The effect of antipsychotics on insulin secretion
KOSHIBA	MAMIKO	O2-F-9	The support effect of antioxidant dietary supplement in elderly social psychology and immune system for preventive medicine
MORIGUCHI	SHIGEKI	O3-C-9	Activation of T-type voltage-dependent calcium channel on cognitive function
Siu	Cynthia	P1-7	Bayesian Predictive Power Analysis for Adaptive Trial Design and Phase II Dose-finding Strategies
TAKEKITA	YOSHITERU	P1-10	Relationship of DRD2 Taq1A polymorphism with perospirone and aripiprazole effi cacy in Japanese schizophrenia patients
KATO	MASAKI	P1-11	5-HTTLPR rs25531A>G differentially influence paroxetine and fluvoxamineantidepressant effi cacy: A randomized-controlled trial
KATO	MASAKI	P1-45	Long-Term Treatment with Lurasidone in Schizophrenia: Results of an 8-week Double-blind Acute Study Followed by a 44-Week Open-Label Extension
SUZUKI	YUTARO	P1-49	QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone
YAMAMOTO	NOBUTOMO	P2-1	The inter-rater reliability of the Structured interview guide for the Hamilton anxiety rating scale (SIGH-A) of the Japanese version
OHI	KAZUTAKA	P2-12	The p250GAP Gene is Associated with Risk for Schizophrenia and Schizotypal Personality Trait
TADORI	YOSHIHIRO	P2-25	Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
YU	ZHIQIAN	P2-37	Therapeutic concentration of lithium stimulates immune related gene expressions in differentiated monocytic cells
NONAKA	AYAKO	P2-50	Diphenhydramine but not levocetirizine or olopatadine impairs consolidation and expression of conditioned fear
YAMADA	SHINNOSUKE	P2-56	Follistatin like-1 involves in polyI:C-induced impairment of neurite outgrowth
MAGARA	SHIORI	P2-59	Cytoprotective effects of sigma 1 receptor chaperone at mitochondria
NAKAMURA	KYOKO	P2-64	Effects of single and repeated electroconvulsive seizure on hippocampal cell proliferation and spontaneous and cognitive behaviors in the rats